Results 121 to 130 of about 38,153 (235)
IJU Case Reports, Volume 9, Issue 2, March 2026.ABSTRACT Introduction Anti‐melanoma differentiation‐associated gene 5 antibody‐positive interstitial lung disease is a rare but fatal adverse event following immune checkpoint inhibitor treatment for cancers. However, such cases have not been previously reported in patients with urothelial carcinoma.
Akira Saito +4 more
wiley +1 more source
Drug Hypersensitivity: A Correlation Study From Histopathology to Clinic
JEADV Clinical Practice, Volume 5, Issue 1, Page 124-131, March 2026.ABSTRACT Background Drug hypersensitivity (DH) can present with varied clinical and pathological manifestations that may mislead the referring physician. Available data regarding the concordance between pathological diagnosis and clinical findings in DH are scarce.
Olivier Philip +5 more
wiley +1 more source
Dermatomyositis: Practical Guidance and Unmet Needs
ImmunoTargets and TherapyLydia Cassard,1 Noelle Seraly,2 Maureen Riegert,3 Aditi Patel,4 Anthony P Fernandez5 1Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, OH, USA; 2Department of Dermatology, Cleveland Clinic, Cleveland, OH, USA ...
Cassard L +4 more
doaj
Clinical Case Reports, 2019 Juvenile dermatomyositis shows characteristic skin lesions. However, this does not rule out co‐occurring other autoimmune diseases, which may be more prominent regarding skin manifestations.
Aleksander Markovic +3 more
doaj +1 more source
Dermatomyositis Like Presentation of Anti‐HMGCR Immune Mediated Necrotising Myopathy
JEADV Clinical Practice, Volume 5, Issue 1, Page 237-240, March 2026.Capsule summary Cutaneous manifestations of HMGCR‐IMNM are rare and poorly described. Dermatomyositis‐like rash manifestation can be a presentation of the HMGCR‐IMNM. We report a case with a dermatomyositis‐like presentation and provide a literature review on this topic.
Lionel Leblanc +4 more
wiley +1 more source
Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review
JEADV Clinical Practice, Volume 5, Issue 1, Page 205-210, March 2026.ABSTRACT Background Psoriasis (PsO) and dermatomyositis (DM) are both autoimmune‐mediated, inflammatory conditions. The concurrence of PsO and DM is rare, and literature on their relationship remains limited. Additionally, cutaneous DM can be challenging to clinically diagnosis, often presenting with psoriasiform clinical features.
Emily R. Gordon +5 more
wiley +1 more source
Clinical Case ReportsAnti‐melanoma differentiation associated protein 5 antibody positive dermatomyositis (anti‐MDA5 dermatomyositis) is characterized by rapidly progressive interstitial lung disease and skin involvement with a paucity of muscle involvement.
Thomas Bond +3 more
doaj +1 more source
Why do patients with myositis die? A retrospective analysis of a single-centre cohort [PDF]
, 2016 OBJECTIVES: Causes of death in inflammatory myopathies have rarely been studied. We have assessed a cohort of myositis patients followed in a single centre over a 37-year period, reviewing the mortality rate, causes of death and predictors of poor ...
Cogollo, E, Isenberg, DA, Silva, MA
core
RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets
MedComm, Volume 7, Issue 3, March 2026.RNA regulatory networks play a crucial role in the initiation and progression of cancer through various modes of RNA interactions. Notably, circulating RNAs have emerged as potential biomarkers, while targeted interventions in RNA regulatory networks facilitate precise therapeutic strategies. ABSTRACT Cancer is a global health challenge. The initiation
Xuan Yin +9 more
wiley +1 more source